Mass. General study finds potential mechanism for BCG vaccine reversal of type 1 diabetes
Interim results from a FDA-approved clinical trial testing the generic vaccine bacillus Calmette-Guérin (BCG) to reverse advanced type 1 diabetes are being presented at the...






